Background and purpose: Post-COVID-19 condition (PCC) is a prevalent and high-burden sequela of SARS-CoV-2 infection. Because of the complexity of its manifestations, PCC case definition currently lacks standardisation and reproducibility. We aimed to devise a simple screening tool to boost reproducibility and comparability of PCC case definition across PCC studies, and to provide a framework in which to reliably identify suspected PCC cases. We also developed a comprehensive assessment protocol based on the most frequently reported PCC characteristics. Methods: Within a European multi-centre study and based on the conclusions of a previous systematic review, we devised a checklist to assess the presence of PCC-associated symptoms and their temporal relationship with COVID-19. Results: The checklist was developed to include three symptom cores (cognitive, psychiatric, and general). For each symptom, onset is assessed within 3 months after COVID-19 resolution and persistence for at least 2 months. Any symptom fulfilling this criterion is sufficient to prompt suspicion of PCC. At least one symptom is required in the cognitive or psychiatric domains to suspect PCC with neuropsychiatric involvement. Our protocol features an extensive neuropsychological evaluation and self-administered scales for mood, anxiety, stress-related symptoms, sleep disorders, quality of life, disability, mental health, and personality traits; scales for quantitative assessment of fatigue and headache are also included. Conclusions: Consistent identification of PCC cases is crucial to correctly include patients in research and clinical studies. We propose a simple, reproducible, and flexible screening tool and a proposal for a comprehensive assessment that could be employed to enhance standardisation and comparability.

Operationalisation of post-COVID condition case definition in a comprehensive research protocol / F. Masserini, A. Nicotra, A. Forgione, F. Calcaterra, E. Perdixi, C. Di Vito, A. Carletti, C. Gallo, P.E. Doneddu, F. Terenghi, S. Pomati, E. Nobile-Orazio, A. Riva, D. Mavilio, L. Pantoni. - In: EUROPEAN JOURNAL OF NEUROLOGY. - ISSN 1468-1331. - 32:1(2025 Jan), pp. e16543.1-e16543.7. [10.1111/ene.16543]

Operationalisation of post-COVID condition case definition in a comprehensive research protocol

F. Masserini
Primo
Membro del Collaboration Group
;
F. Calcaterra
Membro del Collaboration Group
;
C. Di Vito
Membro del Collaboration Group
;
C. Gallo
Membro del Collaboration Group
;
F. Terenghi
Membro del Collaboration Group
;
S. Pomati;E. Nobile-Orazio;A. Riva;D. Mavilio;L. Pantoni
Ultimo
Membro del Collaboration Group
2025

Abstract

Background and purpose: Post-COVID-19 condition (PCC) is a prevalent and high-burden sequela of SARS-CoV-2 infection. Because of the complexity of its manifestations, PCC case definition currently lacks standardisation and reproducibility. We aimed to devise a simple screening tool to boost reproducibility and comparability of PCC case definition across PCC studies, and to provide a framework in which to reliably identify suspected PCC cases. We also developed a comprehensive assessment protocol based on the most frequently reported PCC characteristics. Methods: Within a European multi-centre study and based on the conclusions of a previous systematic review, we devised a checklist to assess the presence of PCC-associated symptoms and their temporal relationship with COVID-19. Results: The checklist was developed to include three symptom cores (cognitive, psychiatric, and general). For each symptom, onset is assessed within 3 months after COVID-19 resolution and persistence for at least 2 months. Any symptom fulfilling this criterion is sufficient to prompt suspicion of PCC. At least one symptom is required in the cognitive or psychiatric domains to suspect PCC with neuropsychiatric involvement. Our protocol features an extensive neuropsychological evaluation and self-administered scales for mood, anxiety, stress-related symptoms, sleep disorders, quality of life, disability, mental health, and personality traits; scales for quantitative assessment of fatigue and headache are also included. Conclusions: Consistent identification of PCC cases is crucial to correctly include patients in research and clinical studies. We propose a simple, reproducible, and flexible screening tool and a proposal for a comprehensive assessment that could be employed to enhance standardisation and comparability.
COVID‐19; case definition; cognitive; post‐COVID condition; psychiatric
Settore MEDS-26/A - Scienze tecniche di medicina di laboratorio
Settore MEDS-12/A - Neurologia
Settore MEDS-02/A - Patologia generale
Settore MEDS-10/B - Malattie infettive
   The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV
   NEUROCOV
   EUROPEAN COMMISSION
   101057775
gen-2025
13-nov-2024
Article (author)
File in questo prodotto:
File Dimensione Formato  
F_Messerini F. Eur. J. Neur.pdf

accesso aperto

Descrizione: Paper Published
Tipologia: Publisher's version/PDF
Dimensione 1.78 MB
Formato Adobe PDF
1.78 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1137485
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
  • OpenAlex ND
social impact